{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:02:53Z","timestamp":1791896573348,"version":"4.3.4"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.533872","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:49:36Z","timestamp":1600429776000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Dopaminergic, Noradrenergic, Adrenal, and Thyroid Abnormalities in Psychotic and Affective Disorders"],"prefix":"10.3389","volume":"11","author":[{"given":"Fabrice","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Mokrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Erb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlad","family":"Danila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Gonzalez Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Jeanjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol Psychiatr"},{"key":"B2","doi-asserted-by":"publisher","first-page":"E1689","DOI":"10.3390\/ijms18081689","article-title":"New targets for schizophrenia treatment beyond the dopamine hypothesis","volume":"18","author":"Yang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0246-1072(16)75332-6","article-title":"Endocrinologie et Psychiatrie [Article in French]","volume":"13","author":"Duval","year":"2016","journal-title":"EMC Psychiatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(88)90033-4","article-title":"Apomorphine in the evaluation of dopaminergic function in man","volume":"12","author":"Lal","year":"1988","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(94)00065-4","article-title":"Multihormonal responses to apomorphine in mental illness","volume":"20","author":"Mokrani","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00201-3","article-title":"The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia","volume":"24","author":"Meltzer","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(99)00098-6","article-title":"Dopaminergic function and the cortisol response to dexamethasone in psychotic depression","volume":"24","author":"Duval","year":"2000","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiat"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00047-1","article-title":"Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests","volume":"28","author":"Duval","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"B9","first-page":"77","article-title":"Multihormonal reponses to a series of neuroendocrine challenges in psychiatry: a multivariate approach","volume-title":"New Prospects in Psychiatry: The Bio-clinical Interface","author":"Duval","year":"1995"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790160098013","article-title":"Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders","volume":"41","author":"Meltzer","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(98)00005-3","article-title":"Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients","volume":"32","author":"Muller-Spahn","year":"1998","journal-title":"J Psychiatr Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jpsychires.2019.02.009","article-title":"Differences in multihormonal responses to the dopamine agonist apomorphine between unipolar and bipolar depressed patients","volume":"112","author":"Monreal","year":"2019","journal-title":"J Psychiatr Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2006.04.003","article-title":"Cortisol hypersecretion in unipolar major depression with melancholic and psychotic features\u00a0: dopaminergic, noradrenergic and thyroid correlates","volume":"31","author":"Duval","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0022-3956(85)90068-8","article-title":"A corticosteroid\/dopamine hypothesis for psychotic depression and related states","volume":"19","author":"Schatzberg","year":"1985","journal-title":"J Psychiatr Res"},{"key":"B15","article-title":"New studies and perspectives on the noradrenergic receptor system in depression: effect of the \u03b12-adrenergic agonist clonidine","volume":"19","author":"Siever","year":"1984","journal-title":"Biol Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(00)00024-X","article-title":"Multihormonal response to clonidine in patients with affective and psychotic symptoms","volume":"25","author":"Mokrani","year":"2000","journal-title":"Psychoneuroendocrinology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/01.psy.0000163456.22154.d2","article-title":"Hypercortisolemia and depression","author":"Gillespie","year":"2005","journal-title":"Psychosom Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-444-59602-4.00005-8","article-title":"Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease","volume":"124","author":"Naughton","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2019.07.003","article-title":"HPA axis in psychotic major depression and schizophrenia spectrum disorders: cortisol, clinical symptomatology, and cognition","volume":"213","author":"Cherian","year":"2019","journal-title":"Schizophr Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.10.1253","article-title":"The dexamethasone suppression test: an overview of its current status in psychiatry","volume":"14","year":"1987","journal-title":"Am J Psychiatry"},{"key":"B21","article-title":"Thyroid Axis Activity in Depression","volume":"4","author":"Duval","year":"2018","journal-title":"Ann Thyroid Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.951","article-title":"The thyroid axis and depression","volume":"8","author":"Jackson","year":"1998","journal-title":"Thyroid"},{"key":"B23","first-page":"361","article-title":"[Schedule for Affective Disorders and Schizophrenia (SADS)] [Article in French]","volume":"87","author":"Endicott","year":"1987","journal-title":"Acta Psychiatr Belg"},{"key":"B24","first-page":"886","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810170043007","article-title":"Difference between evening and morning thyrotropin responses to protirelin in major depressive episode","volume":"47","author":"Duval","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archpsyc.1981.01780260017001","article-title":"A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility","volume":"8","author":"Carroll","year":"1981","journal-title":"Arch Gen Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0165-1781(95)02606-1","article-title":"Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients","volume":"60","author":"Valdivieso","year":"1996","journal-title":"Psychiatry Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0001-2998(78)80014-2","article-title":"Basic principles of ROC analysis","volume":"8","author":"Metz","year":"1978","journal-title":"Semin Nucl Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031746","article-title":"Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding pro les of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J Pharmacol Exp Therapeut"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(92)90145-F","article-title":"D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats","volume":"31","author":"Borowski","year":"1992","journal-title":"Neuropharmacology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00765-2","article-title":"Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus","volume":"738","author":"Eaton","year":"1996","journal-title":"Brain Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-1107-2","article-title":"Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland","volume":"57","author":"Pivonello","year":"2017","journal-title":"Endocrine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244352","article-title":"Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning","volume":"69","author":"Malas","year":"1987","journal-title":"J Neural Transm"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(94)90052-3","article-title":"Noradrenergic and dopaminergic interrelation in schizophrenia","volume":"53","author":"Brambilla","year":"1994","journal-title":"Psychiatry Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(83)90023-4","article-title":"Longitudinal instability of hormone responses in schizophrenia","volume":"7","author":"Cleghorn","year":"1983","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800120048010","article-title":"Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients","volume":"43","author":"Zemlan","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"B40","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amp.2005.04.011","article-title":"Exploration de la fonction dopaminergique dans les depressions bipolares et unipolares","volume":"163","author":"Monreal","year":"2005","journal-title":"Ann Med Psychol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1977.01770220081009","article-title":"A neuroendocrine study of supersensitivity in tardive dyskinesia","volume":"34","author":"Tamminga","year":"1977","journal-title":"Arch Gen Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-351X(05)80180-6","article-title":"Adrenergic control of the secretion of anterior pituitary hormones","volume":"7","author":"Al-Damluji","year":"1993","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.9.1017","article-title":"Overview: toward a dysregulation hypothesis of depression","volume":"142","author":"Siever","year":"1985","journal-title":"Am J Psychiatry"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2017.07.488","article-title":"Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients","volume":"85","author":"Duval","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2018.11.554","article-title":"Relationship between melatonergic and thyroid systems in depression","volume":"3","author":"Duval","year":"2019","journal-title":"Endocrinol Diabetes Metab J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.139.4.405","article-title":"Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review","volume":"139","author":"Loosen","year":"1982","journal-title":"Am J Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c130036","article-title":"Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects","volume":"4","author":"Jacobson","year":"2014","journal-title":"Compr Physiol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(94)90017-5","article-title":"The combined dexamethasone\/ \u2028CRH test: a refined laboratory test for psychiatric disorders","volume":"28","author":"Heuser","year":"1994","journal-title":"J Psychiatr Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2006.03.001","article-title":"The dex\/CRH test is it better than the DST","volume":"31","author":"Watson","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2012.09.032","article-title":"The DEX\/CRH test for major depression: a potentially useful diagnostic test","volume":"208","author":"Mokhtari","year":"2013","journal-title":"Psychiatry Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e4324","DOI":"10.1371\/journal.pone.0004324","article-title":"The combined dexamethasone\/CRH Test (DEX\/CRH test) and prediction of acute treatment response in major depression","volume":"4","author":"Sch\u00fcle","year":"2009","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12993-016-0108-x","article-title":"Clinical application of DEX\/CRH test and multi-channel NIRS in patients with depression","volume":"12","author":"Kinoshita","year":"2016","journal-title":"Behav Brain Funct"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1210\/endo.133.2.8393765","article-title":"Nussdorfer GG Thyrotropin-releasing hormone inhibits glucocorticoid secretion of rat adrenal cortex: in vivo and in vitro studies","volume":"133","author":"Neri","year":"1993","journal-title":"Endocrinology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.154.6.858","article-title":"Tricyclic wash-out and growth hormone response to clonidine","volume":"154","author":"Schittecatte","year":"1989","journal-title":"Brit J Psychiatry"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(90)90018-4","article-title":"The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST","volume":"19","author":"Wiedemann","year":"1990","journal-title":"J Affect Disord"},{"key":"B56","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1001\/archpsyc.1993.01820170073010","article-title":"Dissociation between pituitary and adrenal suppression to dexamethasone in depression","volume":"50","author":"Young","year":"1993","journal-title":"Arch Gen Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.533872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T14:53:15Z","timestamp":1601045595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.533872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":56,"alternative-id":["10.3389\/fpsyt.2020.533872"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.533872","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,18]]},"article-number":"533872"}}